Concepedia

L. Dix

LD

Statistics

Publications

5

Citations

163

H-Index

5

Active since

1986

Affiliations

University of Rochester(Current)

University of North Carolina at Chapel Hill

University of Miami

Brigham and Women's Hospital

Harvard University

L. Dix is an author at University of Rochester specializing in pharmacy, pharmacokinetics, and antiretroviral therapy.

ORCID

Publications per year

1986–2014

5

Publications

5

The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity

Josephine Mauskopf, Randall Austin, L. Dix et al. · Quality of Life Research · 1994 · 49 citations

, , +12

The Effect of Valaciclovir on Cytomegalovirus Viremia and Viruria Detected by Polymerase Chain Reaction in Patients with Advanced Human Immunodeficiency Virus Disease

P. D. Griffiths, Judith Feinberg, J. M. Fry et al. · The Journal of Infectious Diseases · 1998 · 43 citations · Full text

, , +14

Outcomes by Sex Following Treatment Initiation With Atazanavir Plus Ritonavir or Efavirenz With Abacavir/Lamivudine or Tenofovir/Emtricitabine

Kimberly Y. Smith, C. Tierney, Katie R. Mollan et al. · Clinical Infectious Diseases · 2013 · 33 citations · Full text

, , +17

Increased gentamicin nephrotoxicity in normal and diseased dogs administered identical serum drug concentration profiles: increased sensitivity in subclinical renal dysfunction.

Donita L. Frazier, L. Dix, Keith Bowman et al. · Journal of Pharmacology and Experimental Therapeutics · 1986 · 19 citations

, , +15

Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202

Charles S. Venuto, Katie R. Mollan, Qing Ma et al. · Journal of Antimicrobial Chemotherapy · 2014 · 19 citations · Full text

, , +15

1–5 of 5